Group 1 - The movement towards marijuana legalization in the U.S. has gained momentum, positively impacting shares of multistate operators like Curaleaf, which saw a gain of over 10% [1] - President Trump is considering a federal proposal to reclassify marijuana as a less harmful drug, indicating potential changes in federal policy [2] - Republican Congressman Greg Steube has introduced the "Marijuana 1-to-3 Act," aiming to reschedule marijuana from Schedule 1 to Schedule 3, which would effectively legalize it within 60 days of passing [3] Group 2 - Steube has been a long-time advocate for marijuana reform, emphasizing that loosening restrictions would significantly expand research opportunities [4] - Public support for marijuana legalization has increased dramatically, with a Gallup survey indicating 68% support in 2024, up from 36% in 2005, reflecting a shift in societal attitudes towards the drug [4]
Why Curaleaf Stock Rocked the Market Today
The Motley Fool·2025-08-13 20:46